• 1. 902. Polyazanaphthalenes. Part VII. Some derivatives of quinazoline and 1,3,5-triazanaphthalene
  V. Oakes,H. N. Rydon,K. Undheim J. Chem. Soc. 1962 4678

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazanaphthalenes Quinazolines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazanaphthalenes Benzodiazines Quinazolines

Professional Introduction to 2,4-dichloro-6-methyl-quinazoline (CAS No. 39576-82-4)

2,4-dichloro-6-methyl-quinazoline, identified by its Chemical Abstracts Service (CAS) number 39576-82-4, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the quinazoline derivatives, a class of molecules known for their broad spectrum of biological activities. The structural features of 2,4-dichloro-6-methyl-quinazoline, including its chlorine substituents and methyl group, contribute to its unique reactivity and potential utility in synthetic chemistry and drug development.

The quinazoline scaffold is a privileged structure in medicinal chemistry, with numerous derivatives exhibiting pharmacological properties ranging from anticancer to antimicrobial effects. The presence of chloro groups at the 2 and 4 positions enhances the electrophilicity of the molecule, making it a valuable intermediate in the synthesis of more complex pharmacophores. Additionally, the methyl group at the 6 position influences the electronic distribution and steric environment, further modulating its biological interactions.

In recent years, there has been a surge in research focused on quinazoline derivatives as potential therapeutic agents. One of the most compelling areas of investigation has been their application in oncology. Studies have demonstrated that certain quinazoline-based compounds can inhibit key enzymes involved in cancer cell proliferation, such as tyrosine kinases. The mechanism of action often involves disruption of signaling pathways critical for tumor growth and survival. For instance, modifications to the 2,4-dichloro-6-methyl-quinazoline core have led to the development of novel inhibitors that show promise in preclinical models.

Another area where 2,4-dichloro-6-methyl-quinazoline has shown promise is in antimicrobial research. The increasing prevalence of antibiotic-resistant pathogens has necessitated the discovery of new antimicrobial agents. Quinazoline derivatives have been explored for their ability to interfere with bacterial DNA replication and transcription processes. The chlorine atoms in 2,4-dichloro-6-methyl-quinazoline serve as handles for further functionalization, allowing chemists to design molecules with enhanced binding affinity to bacterial targets. Preliminary studies indicate that certain derivatives exhibit potent activity against Gram-positive and Gram-negative bacteria.

The synthetic utility of 2,4-dichloro-6-methyl-quinazoline cannot be overstated. Its versatility as a building block enables the construction of diverse molecular architectures through various chemical transformations. For example, nucleophilic aromatic substitution reactions can be employed to introduce new substituents at the chlorinated positions, while palladium-catalyzed cross-coupling reactions offer pathways to aryl and vinyl analogs. These synthetic strategies have been leveraged to generate libraries of quinazoline derivatives for high-throughput screening.

Advances in computational chemistry have further accelerated the discovery process for 2,4-dichloro-6-methyl-quinazoline derivatives. Molecular modeling techniques allow researchers to predict binding interactions between potential drug candidates and biological targets with high precision. This approach has been instrumental in optimizing lead compounds for better pharmacokinetic properties and reduced toxicity. By integrating experimental data with computational insights, scientists can rationally design next-generation quinazoline-based therapeutics.

The role of 2,4-dichloro-6-methyl-quinazoline in academic and industrial research continues to evolve alongside emerging technologies. Techniques such as flow chemistry and microwave-assisted synthesis have streamlined its preparation, enabling large-scale production for both research and commercial purposes. These innovations have not only improved efficiency but also opened new avenues for structural diversification.

In conclusion,2,4-dichloro-6-methyl-quinazoline (CAS No. 39576-82-4) represents a cornerstone compound in modern pharmaceutical research. Its unique structural features and synthetic accessibility make it an indispensable tool for chemists seeking to develop novel therapeutic agents. As our understanding of biological pathways grows more sophisticated, so too does our capacity to harness the potential of this versatile molecule.

• 20028-68-6(2,4,6-Trichloroquinazoline)
• 62484-27-9(Quinazoline, 2,4-dichloro-6,8-dimethyl-)
• 90272-83-6(4-Chloro-7-methylquinazoline)
• 6625-94-1(2,4,7-Trichloroquinazoline)
• 864292-40-0(2,4-Dichloroquinazoline-7-carbonitrile)
• 150449-98-2(2,4-Dichloroquinazoline-6-carbonitrile)
• 25171-19-1(2,4-dichloro-7-methyl-quinazoline)
• 607-68-1(2,4-Dichloroquinazoline)
• 79689-46-6(Quinazoline, 2,4-dichloro-6-ethyl-)
• 62484-28-0(Quinazoline, 2,4-dichloro-7,8-dimethyl-)